C5aR1促进皮肤状细胞癌的侵袭,转移和不良预后
Lauri Heiskanen1, Liisa Nissinen1, Elina Siljamäki2
1Department of Dermatology, University of Turku and Turku University Hospital, Turku, Finland; FICAN West Cancer Research Laboratory, University of Turku and Turku University Hospital, Turku, Finland.
The American journal of pathology
|March 8, 2025
概括
补剂C5a受体C5aR1在皮肤状细胞癌 (cSCC) 中升高,并与转移增加和患者存活率低下有关. 针对C5aR1可能为高级cSCC提供新的治疗策略.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 皮肤病学 皮肤病学
背景情况:
- 皮肤状细胞癌 (cSCC) 是一种流行转移性皮肤癌,预后不佳.
- 补充系统,特别是C5a受体1 (C5aR1) 在cSCC进展和转移中的作用尚不清楚.
研究的目的:
- 研究C5aR1在cSCC.转移的发展和转移中的表达和功能.
- 评估C5aR1作为转移风险和cSCC患者存活率的潜在生物标志物.
主要方法:
- 采用了三维球形共同培养模型与纤维细胞和重组C5a治疗.
- 在人类cSCC异种移植,初级cSCC,前恶性病变和正常皮肤中使用多重免疫光和免疫组织化学分析了C5aR1表达.
主要成果:
- 在与纤维细胞共同培养的cSCC细胞中,C5aR1表达被上调,C5a增强了cSCC细胞入侵.
- 在侵袭性cSCC的瘤细胞和纤维细胞中发现C5aR1的升高,包括与衰退性性表皮溶解相关的cSCC.
- 在原发性cSCC患者中,增加C5aR1表达与更高的转移风险和较差的疾病特异性生存率相关.
结论:
- C5a信号传递有助于cSCC细胞入侵.
- C5aR1作为一种新的生物标志物,用于预测cSCC患者的转移风险和预后.
- C5aR1代表了局部晚期和转移性cSCC的潜在治疗点.
相关概念视频
Cancer Cell Migration through Invadopodia
2.3K
Invadosome is a broad category of cell surface structures with proteolytic activity that degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
2.3K
Metastasis
5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K
Mitogens and the Cell Cycle
6.4K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K
Skin Cancer
4.0K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
4.0K
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
Tumor Progression
6.3K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K


